𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

✍ Scribed by Sherene Loi; Benjamin Haibe-Kains; Christine Desmedt; Pratyaksha Wirapati; Françoise Lallemand; Andrew M Tutt; Cheryl Gillet; Paul Ellis; Kenneth Ryder; James F Reid; Maria G Daidone; Marco A Pierotti; Els MJJ Berns; Maurice PHM Jansen; John A Foekens; Mauro Delorenzi; Gianluca Bontempi; Martine J Piccart; Christos Sotiriou

Book ID
115004598
Publisher
BioMed Central
Year
2008
Tongue
English
Weight
464 KB
Volume
9
Category
Article
ISSN
1471-2164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of early recurrence among postmenop
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi